Sabnis et al. A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates. Mol. Ther. 2018; 26(6):1509-1519
https://www.ncbi.nlm.nih.gov/pubmed/29653760
Hassett et al. Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines. Mol Ther Nucleic Acids. 2019; 15:1-11 https://www.ncbi.nlm.nih.gov/pubmed/30785039
Moderna Announces Positive Interim Results from Phase 1 Cytomegalovirus (CMV) Vaccine (mRNA-1647) Study and Progress Toward Phase 2 and Pivotal Trials https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-positive-interim-results-phase-1
John et al. Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity. Vaccine. 2018; 36(12):1689-1699 https://www.ncbi.nlm.nih.gov/pubmed/29456015
Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA-1944). https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-positive-phase-1-results-first-systemic
Kose et al. A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection. Sci Immunol.; 4(35) https://www.ncbi.nlm.nih.gov/pubmed/31101672
Hewitt et al. Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs. Sci Transl Med.; 11(477). https://www.ncbi.nlm.nih.gov/pubmed/30700577